Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.33 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.32 |
| ▸ | MAOA | P21397 | 4/20 | 0.32 |
| ▸ | MAOB | P27338 | 4/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | TNF | P01375 | 1/20 | 0.32 |
| ▸ | CDC7 | O00311 | 1/20 | 0.31 |
| ▸ | CDK2 | P24941 | 1/20 | 0.31 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.31 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30709511 | 0.89 | MAPT (0.33) | KDM4EMEN1KMT2A | |
| SCHEMBL30709323 | 0.88 | NPY5R (0.33) | ATMKDM4EL3MBTL1PTGER4NPY5R | |
| SCHEMBL30709509 | 0.88 | MAOA (0.33) | ATMKDM4EL3MBTL1MAOAMAOB | |
| SCHEMBL30709444 | 0.84 | MAOA (0.32) | ATMKDM4EL3MBTL1MAOAMAOB | |
| SCHEMBL30709351 | 0.84 | NPY5R (0.33) | NPY5RMAOAMAOBACHEMAPK10 | |
| SCHEMBL30709343 | 0.83 | NPY5R (0.32) | NPY5RMAPK10 | |
| SCHEMBL17349356 | 0.82 | ATM (0.42) | ATMKDM4EL3MBTL1PTGER4NPY5R | |
| SCHEMBL22148542 | 0.81 | MAOA (0.38) | ATMMAOAMAOBACHEALOX5 | |
| SCHEMBL30709170 | 0.81 | MAOA (0.38) | ATMMAOAMAOBACHEALOX5 | |
| SCHEMBL17349688 | 0.81 | KDM4E (0.37) | ATMKDM4EL3MBTL1PTGER4NPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | KYULUX, INC. (JP) | 2023-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | NDUFV3, NDUFV2, CRY2 | ATM 2778/4885KDM4E 4409/4885L3MBTL1 1938/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.